BIPIX vs. DXNLX

Last updated Jun 4, 2026

BIPIX (ProFunds Biotechnology UltraSector Fund) and DXNLX (Direxion Monthly NASDAQ-100 Bull 1.25X Fund) are both Leveraged Equities funds. Over the past 5 years, BIPIX returned 0.73%/yr vs 19.45%/yr for DXNLX. A 0.59 correlation means they provide meaningful diversification when combined. BIPIX charges 1.49%/yr vs 1.19%/yr for DXNLX.

Performance

BIPIX vs. DXNLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProFunds Biotechnology UltraSector Fund (BIPIX) and Direxion Monthly NASDAQ-100 Bull 1.25X Fund (DXNLX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BIPIX achieves a 4.28% return, which is significantly lower than DXNLX's 25.47% return.

BIPIX

• 1D: -6.59%
• 1M: -6.97%
• YTD: 4.28%
• 6M: 4.61%
• 1Y: 83.18%
• 3Y*: 4.78%
• 5Y*: 0.73%
• 10Y*: 6.09%

DXNLX

• 1D: 0.59%
• 1M: 13.43%
• YTD: 25.47%
• 6M: 23.05%
• 1Y: 49.65%
• 3Y*: 32.52%
• 5Y*: 19.45%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BIPIX vs. DXNLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BIPIX ProFunds Biotechnology UltraSector Fund	4.28%	47.99%	-25.91%	9.55%	-13.43%	5.00%	19.94%	23.65%	-12.15%	30.73%
DXNLX Direxion Monthly NASDAQ-100 Bull 1.25X Fund	25.47%	22.13%	28.56%	66.63%	-40.88%	32.49%	58.90%	46.34%	-3.37%	37.37%

Correlation

The correlation between BIPIX and DXNLX is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.44
Correlation (3Y) Calculated over the trailing 3-year period	0.46
Correlation (5Y) Calculated over the trailing 5-year period	0.53
Correlation (All Time) Calculated using the full available price history since Jan 4, 2017	0.59

The correlation between BIPIX and DXNLX shifts across timeframes, from 0.44 (1 year) to 0.59 (all time), reflecting how their relationship changes across market environments.

Return for Risk

BIPIX vs. DXNLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIPIX

BIPIX Risk / Return Rank: 67
BIPIX Sharpe Ratio Rank: 60
BIPIX Sortino Ratio Rank: 49
BIPIX Omega Ratio Rank: 43
BIPIX Calmar Ratio Rank: 95
BIPIX Martin Ratio Rank: 88

DXNLX

DXNLX Risk / Return Rank: 65
DXNLX Sharpe Ratio Rank: 78
DXNLX Sortino Ratio Rank: 60
DXNLX Omega Ratio Rank: 59
DXNLX Calmar Ratio Rank: 70
DXNLX Martin Ratio Rank: 60

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIPIX vs. DXNLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProFunds Biotechnology UltraSector Fund (BIPIX) and Direxion Monthly NASDAQ-100 Bull 1.25X Fund (DXNLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BIPIX	DXNLX	Difference
Sharpe ratio: Return per unit of total volatility	2.28	2.56	-0.28
Sortino ratio: Return per unit of downside risk	2.96	3.25	-0.29
Omega ratio: Gain probability vs. loss probability	1.35	1.43	-0.08
Calmar ratio: Return relative to maximum drawdown	5.75	3.23	+2.52
Martin ratio: Return relative to average drawdown	17.49	11.90	+5.59
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BIPIX vs. DXNLX - Sharpe Ratio Comparison

The current BIPIX Sharpe Ratio is 2.28, which is comparable to the DXNLX Sharpe Ratio of 2.56. The chart below compares the historical Sharpe Ratios of BIPIX and DXNLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BIPIX	DXNLX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.28	2.56	-0.28
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.02	0.69	-0.67
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.17	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.15	0.86	-0.70

Drawdowns

BIPIX vs. DXNLX - Drawdown Comparison

The maximum BIPIX drawdown since its inception was -84.51%, which is greater than DXNLX's maximum drawdown of -43.77%. Use the drawdown chart below to compare losses from any high point for BIPIX and DXNLX.

Drawdown Indicators

	BIPIX	DXNLX	Difference
Max Drawdown Largest peak-to-trough decline	-84.51%	-43.77%	-40.74%
Max Drawdown (1Y) Largest decline over 1 year	-15.15%	-15.91%	+0.76%
Max Drawdown (3Y) Largest decline over 3 years	-59.50%	-28.35%	-31.15%
Max Drawdown (5Y) Largest decline over 5 years	-63.86%	-43.77%	-20.09%
Max Drawdown (10Y) Largest decline over 10 years	-63.86%	—	—
Current Drawdown Current decline from peak	-16.45%	0.00%	-16.45%
Average Drawdown Average peak-to-trough decline	-37.22%	-8.71%	-28.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.97%	4.31%	+0.66%

Volatility

BIPIX vs. DXNLX - Volatility Comparison

ProFunds Biotechnology UltraSector Fund (BIPIX) has a higher volatility of 14.22% compared to Direxion Monthly NASDAQ-100 Bull 1.25X Fund (DXNLX) at 5.54%. This indicates that BIPIX's price experiences larger fluctuations and is considered to be riskier than DXNLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BIPIX	DXNLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.22%	5.54%	+8.68%
Volatility (6M) Calculated over the trailing 6-month period	30.38%	15.18%	+15.20%
Volatility (1Y) Calculated over the trailing 1-year period	38.37%	20.04%	+18.33%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	39.70%	28.25%	+11.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	36.37%	28.84%	+7.53%

BIPIX vs. DXNLX - Expense Ratio Comparison

BIPIX has a 1.49% expense ratio, which is higher than DXNLX's 1.19% expense ratio.

Dividends

BIPIX vs. DXNLX - Dividend Comparison

BIPIX's dividend yield for the trailing twelve months is around 0.35%, less than DXNLX's 0.79% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
BIPIX ProFunds Biotechnology UltraSector Fund	0.35%	0.37%	0.23%	6.69%	0.00%	0.79%	12.09%	3.26%	5.52%	7.19%
DXNLX Direxion Monthly NASDAQ-100 Bull 1.25X Fund	0.79%	2.31%	0.17%	0.00%	0.00%	7.43%	12.20%	0.00%	8.79%	7.52%

Frequently Asked Questions

Can I hold both BIPIX and DXNLX in my portfolio?

BIPIX and DXNLX have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BIPIX or DXNLX?

BIPIX has higher volatility (14.22%) compared to DXNLX (5.54%). In terms of maximum drawdown, BIPIX dropped -84.51% vs DXNLX's -43.77%.

Which has better risk-adjusted returns?

DXNLX currently has the higher Sharpe Ratio (2.56 vs 2.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.